Retrotransposons in Werner syndrome-derived macrophages trigger type I interferon-dependent inflammation in an atherosclerosis model
DOI: 10.1038/s41467-024-48663-w
Authors: Sudip Kumar Paul; Motohiko Oshima; Ashwini Patil; Masamitsu Sone; Hisaya Kato; Yoshiro Maezawa; Hiyori Kaneko; Masaki Fukuyo; Bahityar Rahmutulla; Yasuo Ouchi; Kyoko Tsujimura; Mahito Nakanishi; Atsushi Kaneda; Atsushi Iwama; Koutaro Yokote; Koji Eto; Naoya Takayama
Step 1: iPSC/ESC maintainance
day 0 ~ 1 (duration missing in database; assumed 1 day)
culture “adherent” human PSC in “AK02N medium”. For ECM, use “Matrigel” at “N/A” “N/A”. Medium should contain factors shown in the following table.
| concentration | unit | |
|---|---|---|
| Y27632 | 1.0e-6 | mol/l |
Ideally, “PSC” should be obtained at the end of culture.
Step 2: Primitive streak 1
day 1 ~ 4
culture “adherent” human PSC in “unspecified medium” for “3” days. Medium should contain factors shown in the following table, and should be changed once in “3” days.
| concentration | unit | |
|---|---|---|
| VEGF | 2.0e-5 | g/l |
Ideally, “PS” should be obtained at the end of culture.
Step 3: endothelial 1
day 4 ~ 11
culture “adherent” human VPC in “unspecified medium” for “7” days. Medium should contain factors shown in the following table, and should be changed once in “7” days.
| concentration | unit | |
|---|---|---|
| VEGF | 1.0e-4 | g/l |
| FBS | 10 | % |
Ideally, “EC” should express “CDH5”, “KDR”, “CD34”, “PECAM1”, “VWF”, “NOS3” at the end of culture.